ArticleBritish journal of cancer2010

Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs.

K Brookes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.